{
    "clinical_study": {
        "@rank": "102404", 
        "acronym": "AION", 
        "arm_group": [
            {
                "arm_group_label": "Enhanced External conterpulsation", 
                "arm_group_type": "Active Comparator", 
                "description": "Enhanced external counterpulsation (EECP) is a noninvasive modality for the treatment of ischemic cardiovascular disease. EECP therapy is done by sequential inflation of 3 sets of cuffs wrapped around the lower extremities during diastole and deflation of the cuffs during systole."
            }, 
            {
                "arm_group_label": "aspirin", 
                "arm_group_type": "Active Comparator", 
                "description": "The subjects with Anterior ischemic Optic Neuropathy received aspirin therapy."
            }
        ], 
        "brief_summary": {
            "textblock": "Enhanced External Counterpulsation(EECP) therapy may promote the recovery of visual function\n      by improving  the blood perfusion of eyes. The present study aims to investigate the effect\n      of EECP on Anterior Ischemic Optic Neuropathy."
        }, 
        "brief_title": "Effect of EECP on Anterior Ischemic Optic Neuropathy", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Anterior Ischemic Optic Neuropathy", 
        "condition_browse": {
            "mesh_term": [
                "Ischemia", 
                "Optic Nerve Diseases", 
                "Optic Neuropathy, Ischemic", 
                "Demyelinating Diseases", 
                "Polyneuropathies", 
                "Nerve Compression Syndromes", 
                "Neurologic Manifestations", 
                "Neurotoxicity Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with Anterior Ischemic Optic Neuropathy are randomized into two groups: one group\n      receive standard medical treatment for ischemic optic neuropathy, the other group plus EECP\n      therapy besides standard medical treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ischemic optic neuropathy\n\n          -  within 1 month\n\n        Exclusion Criteria:\n\n          -  Hemorrhagic disease\n\n          -  thrombophlebitis or infection lesions\n\n          -  severe hypertensive patients\n\n          -  Atrial fibrillation\n\n          -  Aortic regurgitation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01768260", 
            "org_study_id": "Eye EECP-1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Enhanced External conterpulsation", 
                "description": "EECP is performed for 1 hours every day, for a total of 36 hours.", 
                "intervention_name": "Enhanced external counterpulsation", 
                "intervention_type": "Device", 
                "other_name": "EECP"
            }, 
            {
                "arm_group_label": [
                    "Enhanced External conterpulsation", 
                    "aspirin"
                ], 
                "description": "Standard drug therapy", 
                "intervention_name": "Aspirin", 
                "intervention_type": "Drug", 
                "other_name": "aspirin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Aspirin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "visual acuity", 
            "artery flow velocity", 
            "Enhanced External Counterpulsation", 
            "Ischemic", 
            "Optic Neuropathy"
        ], 
        "lastchanged_date": "August 18, 2013", 
        "location": {
            "contact": {
                "email": "Zhanglingaben@126.com", 
                "last_name": "Ling Zhang, MA", 
                "phone": "862087755766", 
                "phone_ext": "8035"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510080"
                }, 
                "name": "The First Affiliated Hospital of Sun Yat- sen University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Effect of EECP on Anterior Ischemic Optic Neuropathy", 
        "other_outcome": {
            "measure": "Central retinal artery flow velocity", 
            "safety_issue": "No", 
            "time_frame": "7 weeks"
        }, 
        "overall_contact": {
            "email": "Zhyan3@mail.sysu.edu.cn", 
            "last_name": "Yan Zhang, MD", 
            "phone": "862087755766", 
            "phone_ext": "8141"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital of Sun Yat-sen University", 
            "last_name": "Yan Zhang, Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: National Natural Science Foundation", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "visual acuity", 
            "safety_issue": "No", 
            "time_frame": "7 weeks"
        }, 
        "reference": {
            "PMID": "15300074", 
            "citation": "Werner D, Michalk F, Harazny J, Hugo C, Daniel WG, Michelson G. Accelerated reperfusion of poorly perfused retinal areas in central retinal artery occlusion and branch retinal artery occlusion after a short treatment with enhanced external counterpulsation. Retina. 2004 Aug;24(4):541-7."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01768260"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "investigator_full_name": "WenHui Zhu", 
            "investigator_title": "Oculist-in-charge", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Ophthalmic artery blood flow velocity", 
            "safety_issue": "No", 
            "time_frame": "7 weeks"
        }, 
        "source": "First Affiliated Hospital, Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "First Affiliated Hospital, Sun Yat-Sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}